Vertex Pharmaceuticals (europe) Limited

United Kingdom


Order your weekly watch
Total IP 17
Total IP Rank # 89,568
IP Activity Score 1.4/5.0    5
IP Activity Rank # 197,982
Parent Entity Vertex Pharmaceuticals Incorporated

Patents

Trademarks

11 0
2 0
4 0
0
 
Last Patent 2022 - Deuterated cftr potentiators
First Patent 2013 - Deuterated cftr potentiators

Latest Inventions, Goods, Services

2020 Invention Deuterated cftr potentiators. This invention relates to compounds of Formula I: This invention...
Invention Administration of deuterated cftr potentiators. Disclosed is a method of treating in a subject o...
Invention Methods of treatment with deuterated cftr potentiators. Disclosed is a method of treating in a s...
2019 Invention Deuterated cftr potentiators. This invention relates to compounds of Formula I: and pharmaceuti...
2018 Invention Deuterated cftr modulators. This invention relates to novel, deuterated forms of VX-661 and pharm...
2017 Invention Methods of treatment with deuterated cftr potentiators. Disclosed is a method of treating in a su...
Invention Deuterium-modified cftr modulators. This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-d...
Invention Deuterium-modified cftr modulators. This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-di...
2016 Invention Deuterated cftr potentiators. This invention relates to compounds of Formula (I) and pharmaceutic...
Invention Administration of deuterated cftr potentiators. Disclosed is a method of treating in a subject of...
Invention Deuterated vx-661. This invention relates to deuterated compounds of Formula A:, andph...